Sofwave Medical Ltd (SOFW) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sofwave Medical Ltd (SOFW) has a cash flow conversion efficiency ratio of -0.014x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-494.69K ≈ $-1.33K USD) by net assets (ILA35.33 Million ≈ $94.73K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Sofwave Medical Ltd (SOFW) balance sheet quality index to measure how much of total assets are equity-financed.
Sofwave Medical Ltd - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Sofwave Medical Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Sofwave Medical Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Sofwave Medical Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sofwave Medical Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Beijing Zhongkehaixun Digital S T
SHE:300810
|
-0.106x |
|
Canopy Growth Corp
TO:WEED
|
-0.023x |
|
KKR Real Estate Finance Trust Inc
NYSE:KREF
|
0.011x |
|
Guangdong VTR Bio-Tech Co Ltd
SHE:300381
|
0.021x |
|
SGC Energy Co Ltd
KO:005090
|
-0.033x |
|
Banco Santander Brasil SA
BA:BSBR
|
0.309x |
|
Shenzhen Ellassay Fashion Co
SHG:603808
|
0.066x |
|
Hes Technology Group
SHE:002963
|
0.058x |
Annual Cash Flow Conversion Efficiency for Sofwave Medical Ltd (2019–2025)
The table below shows the annual cash flow conversion efficiency of Sofwave Medical Ltd from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see Sofwave Medical Ltd market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ILA32.72 Million ≈ $87.71K |
ILA15.08 Million ≈ $40.44K |
0.461x | +571.96% |
| 2024-12-31 | ILA24.53 Million ≈ $65.75K |
ILA-2.40 Million ≈ $-6.42K |
-0.098x | +59.19% |
| 2023-12-31 | ILA26.34 Million ≈ $70.62K |
ILA-6.31 Million ≈ $-16.91K |
-0.239x | +27.61% |
| 2022-12-31 | ILA32.34 Million ≈ $86.70K |
ILA-10.69 Million ≈ $-28.67K |
-0.331x | -636.46% |
| 2021-12-31 | ILA46.70 Million ≈ $125.21K |
ILA-2.10 Million ≈ $-5.62K |
-0.045x | +98.57% |
| 2020-12-31 | ILA1.53 Million ≈ $4.11K |
ILA-4.80 Million ≈ $-12.88K |
-3.133x | -336.15% |
| 2019-12-31 | ILA4.12 Million ≈ $11.03K |
ILA-2.96 Million ≈ $-7.92K |
-0.718x | -- |
About Sofwave Medical Ltd
SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin firming and rejuvenation, tissue renewal, treatment of muscle, aging, and other physiological change in Israel, the United States, Europe, Southeast Asia, the Middle East, and internationally. The company offers an ultrasound technology that induces coagulation and … Read more